Integrated BioPharma, Inc. Stock Other OTC
Equities
INBP
US45811V1052
Pharmaceuticals
Sales 2022 | 56.25M 76.81M | Sales 2023 | 50.67M 69.2M | Capitalization | 9.92M 13.55M |
---|---|---|---|---|---|
Net income 2022 | 3M 4.1M | Net income 2023 | - 0 | EV / Sales 2022 | 0.3 x |
Net Debt 2022 | 1.71M 2.34M | Net Debt 2023 | 1.36M 1.85M | EV / Sales 2023 | 0.22 x |
P/E ratio 2022 |
4.17
x | P/E ratio 2023 |
-292
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 20.22% |
Managers | Title | Age | Since |
---|---|---|---|
Riva Sheppard
CEO | Chief Executive Officer | 57 | 91-04-30 |
Christina Kay
CEO | Chief Executive Officer | 54 | 94-11-30 |
Dina Masi
DFI | Director of Finance/CFO | 63 | 05-11-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christina Kay
CEO | Chief Executive Officer | 54 | 94-11-30 |
Damon Desantis
BRD | Director/Board Member | 56 | 22-06-19 |
Eric Friedman
BRD | Director/Board Member | 76 | 20-11-03 |
1st Jan change | Capi. | |
---|---|---|
+55.19% | 801B | |
+47.26% | 631B | |
-6.09% | 359B | |
+21.92% | 337B | |
+18.40% | 245B | |
+3.64% | 231B | |
+12.98% | 219B | |
+10.86% | 171B | |
-2.78% | 161B |